Acrodermatitis Continua of Hallopeau Successfully Treated With Bimekizumab

Acrodermatitis Continua of Hallopeau Successfully Treated With Bimekizumab

Authors

  • Andrea Pagliara IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di Sant'Orsola, Dermatology Unit
  • Federico Bardazzi 1. IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di Sant'Orsola, Dermatology Unit.
  • Lidia Sacchelli 1. IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di Sant'Orsola, Dermatology Unit.
  • Federica Filippi 2. Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
  • Camilla Loi 1. IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di Sant'Orsola, Dermatology Unit.
  • Bianca Maria Piraccini 2. Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
  • Giacomo Clarizio 2. Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.

Keywords:

psoriasis, hallopeau, biologics, bimekizumab, anti-TNF

References

Ranugha PS, Kumari R, Thappa DM. Acrodermatitis continua of hallopeau evolving into generalised pustular psoriasis. Indian J Dermatol. 2013 Mar;58(2):161.

Cirone KD, Lovegrove FE. Acrodermatitis continua of Hallopeau successfully treated with bimekizumab: A case report. SAGE Open Med Case Rep. 2023 Mar 21;11:2050313X231160937.

Downloads

Published

2024-10-30

How to Cite

1.
Pagliara A, Bardazzi F, Sacchelli L, et al. Acrodermatitis Continua of Hallopeau Successfully Treated With Bimekizumab. Dermatol Pract Concept. 2024;14(4):e2024279. doi:10.5826/dpc.1404a279

Share